The 2026 MLB trade deadline arrives on August 3, and the struggling Detroit Tigers hold the defining piece of the market. Detroit just suffered a sweep by Cleveland and sits tied with the Houston Astros for the second-worst record in the American League.
Head of baseball operations Scott Harris is known for his pragmatic approach to competitive windows. With his ace becoming a free agent at the end of the 2026 season and owed roughly $11 million for the final two months, rival evaluators expect Detroit to demand a historic prospect return, according to Buster Olney’s latest deadline breakdown.
Skubal’s soaring trade value hinges entirely on a groundbreaking medical procedure. He is the first major league pitcher to undergo surgery using the NanoNeedle Scope 2.0, a technique performed by renowned surgeon Dr. Neal ElAttrache that is rewriting established recovery expectations.
This new approach bypasses the traditional two-to-three-month window required for standard arthroscopic procedures. Medical experts anticipate the cutting-edge method will expedite Skubal’s return to the mound to just two months, positioning him as a high-end rotation arm for a playoff contender.
The San Diego Padres are already circling. Aggressive general manager A.J. Preller is reportedly one of the few front-office executives willing to meet Detroit’s high asking price and construct the necessary prospect package to land the left-hander.